Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 1,696.10
-28.00 (-1.62%)
At close: Mar 30, 2026
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 279.44 billion as of March 30, 2026. Its market cap has increased by 4.06% in one year.
Market Cap
279.44B
Enterprise Value
250.45B
Revenue
61.13B
Ranking
n/a
PE Ratio
32.99
Stock Price
1,696.10
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has decreased from 297.10B to 279.44B, a decrease of -5.94%. That is a compound annual growth rate of -1.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 284.06B | 0.12% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 639.02B |
| Glenmark Pharmaceuticals | 612.52B |
| Laurus Labs | 544.61B |
| Ipca Laboratories | 402.37B |
| Ajanta Pharma | 350.67B |
| Emcure Pharmaceuticals | 313.33B |
| Wockhardt | 193.28B |
| Piramal Pharma | 190.63B |